Related Experiment Video

Updated: Jun 25, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

[Hairy cell leukemia in young patients]

L S Al'-Radi, R S Samoĭlova, L Iu Tikhonova

    Terapevticheskii Arkhiv
    |February 21, 2009
    PubMed

    Insights

    Young patients with hair cell leukemia (HCL) exhibit distinct clinical features and treatment responses. Further research is needed to optimize adjuvant therapies for this specific patient group to improve remission duration.

    Area of Science:

    • Hematology
    • Oncology

    Context:

    • Hair cell leukemia (HCL) is a rare chronic lymphoid leukemia.
    • A significant incidence of HCL occurs in young patients, necessitating specific clinical characterization.

    Purpose:

    • To delineate the clinical presentation, disease course, and treatment outcomes in pediatric and young adult patients diagnosed with HCL.
    • To identify unique aspects of HCL in younger individuals compared to the general patient population.

    Summary:

    • Analysis of 41 HCL patients revealed a 26% incidence in young individuals.
    • Young HCL patients present with unique clinical manifestations and respond differently to standard treatment protocols.
    • Recurrence rates vary significantly in young HCL patients post-standard therapy, indicating a need for tailored treatment approaches.

    Impact:

    • Highlights the need to classify young HCL patients as a distinct cohort for treatment strategies.
    • Suggests the requirement for adjuvant therapies to prolong remission in young HCL patients.
    • Informs clinical practice regarding the management of HCL in younger demographics.
    Abstract

    Related Concept Videos

    Bone Marrow Sampling and Transplants01:22

    Bone Marrow Sampling and Transplants

    Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
    The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
    Stem Cell Therapy for Tissue Regeneration01:21

    Stem Cell Therapy for Tissue Regeneration

    Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
    Types of Stem Cells used in Stem Cell Therapy
    The two main cell types that...